← ANALYSTS · TIPRANKS
Kalpit Patel · Wolfe Research
Hits
39%
63 of 162 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+16.1%
Over a year after the rating, TipRanks’ measure
Our companies rated now
17
Buy / hold / sell: 11 / 5 / 1
Upside of the analyst’s targets
+37.2%
Average over 8 current targets, to the last price
The market’s answer to the ratings
+4.8%
Day-0 move against SPY in the rating’s direction, average over 10 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 17on TipRanks 07:25 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Initiated | Buy | — | — | −0.1%next day −1.5% · 5 days −1.6% | ↗ |
| Sep 17on TipRanks 07:25 | VSTMIWMVerastem · $836M | Initiated | Buy | — | — | +2.0%next day −1.6% · 5 days +2.5% | ↗ |
| Sep 17on TipRanks 07:25 | ZYMEIWMZymeworks · $1.8B | Initiated | Buy | — | — | +3.6%next day −3.4% · 5 days −3.3% | ↗ |
| Sep 17on TipRanks 07:25 | TSHAIWMTaysha Gene Therapies · $1.2B | Initiated | Buy | — | — | +0.6%next day −2.8% · 5 days −8.0% | ↗ |
| Aug 24on TipRanks 06:25 | JANXIWMJanux Therapeutics Inc · $1.1B | Upgrade | Buy | $23.00 | +39.3% | +7.3%next day +0.1% · 5 days −2.5% | ↗ |
| Aug 16on TipRanks Aug 17 08:55 | SMMTSummit Therapeutics · $12.4B | Reiterated | Hold | — | — | −3.8%next day +1.0% · 5 days +0.8% | ↗ |
| Aug 11on TipRanks Aug 12 10:15 | KRYSIWMKrystal Biotech · $9.8B | Reiterated | Hold | — | — | −1.0%next day +1.5% · 5 days +2.2% | ↗ |
| Aug 10on TipRanks 08:20 | RVMDRevolution Medicines · $41.5B | Reiterated | Buy | $165 → $220+33.3% | +23.6% | +0.9%next day −0.4% · 5 days +2.5% | ↗ |
| Aug 9on TipRanks Aug 10 08:20 | ONCBeOne Medicines · $40.3B | Assigned | Buy | $340 → $370+8.8% | +0.3% | +3.1%next day +0.4% · 5 days +1.0% | ↗ |
| Jul 29on TipRanks Jul 30 11:25 | CORTCorcept Therapeutics · $12.9B | Reiterated | Sell | $50.00 | −54.6% | +0.2%next day +25.6% · 5 days +13.6% | ↗ |
| Jun 14on TipRanks Jun 15 07:50 | GMABGenmab · $22.3B | Reiterated | Buy | $32.00 | −13.5% | −3.8%next day +1.2% · 5 days +8.1% | ↗ |
| Jun 8on TipRanks 11:50 | TNGXIWMTango Therapeutics · $3.8B | Upgrade | Buy | $35.00 | +58.8% | +52.7%next day +2.3% · 5 days +4.3% | ↗ |
| May 26on TipRanks 11:45 | CGONIWMCG Oncology, Inc. · $5.5B | Reiterated | Hold | — | — | −4.3%next day −1.7% · 5 days −11.5% | ↗ |
| May 19on TipRanks 06:15 | TYRAIWMTyra Bioscience · $1.3B | Initiated | Hold | — | — | −4.6%next day −2.1% · 5 days −4.1% | ↗ |
| May 19on TipRanks 06:15 | MIRMIWMMirum Pharmaceuticals · $5.3B | Initiated | Buy | $145 | +80.9% | +0.8%next day +0.3% · 5 days −0.5% | ↗ |
| May 19on TipRanks 06:15 | CTMXIWMCytomX Therapeutics · $486M | Initiated | Buy | $6.00 | +163.2% | +4.7%next day +1.2% · 5 days +2.4% | ↗ |
| Mar 26on TipRanks 16:20 | OLMAIWMOlema Pharmaceuticals · $601M | Initiated | Hold | — | — | −1.5%next day −1.5% · 5 days +7.1% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗